Thyrotoxicosis Clinical Trial
Official title:
Preoperative Therapeutic Plasma Exchange and Surgical Treatment in Thyrotoxicosis Patients: a Single-centre Retrospective Cohort Study
Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.
Background: Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid
medications cannot be used due to the side effects or attain no adequate hormonal suppression
response at the highest dosage and in cases of rapid onset of clinical symptoms. This study
presents the treatment results of patients who underwent TPE and subsequently operated for
thyrotoxicosis.
Methods: The files of 27 patients who underwent preoperative TPE for thyrotoxicosis between
January 1999 and February 2019 were retrospectively analyzed. The demographic and clinical
features of the patients were included.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06391515 -
Subacute Thyroiditis in the SARS-CoV-2 Era
|
||
| Completed |
NCT03009357 -
Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
|
||
| Recruiting |
NCT02886949 -
The Association Between Autoimmune or Inflammation and Thyroid Disease
|
||
| Not yet recruiting |
NCT06264544 -
Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism
|
N/A | |
| Completed |
NCT01227499 -
Differential Diagnosis of STA-PSV in Thyrotoxicosis
|
N/A | |
| Completed |
NCT02767245 -
Thiamine Supplement in Patients With Severe Hyperthyroidism
|
N/A | |
| Recruiting |
NCT04806269 -
Biosignals by Wearables in Thyroid Dysfunction
|